Novo Nordisk threatens legal action over Hims Wegovy copy (updated) Kimberly Redmond 6, 2026// The basics: Novo Nordisk warns Hims & Hers over $49 compounded, copycat version of Wegovy Drugmaker says product infringes on its branded GLP-1 treatment Hims offering lower-cost compounded weight-loss alternatives amid soaring demand Dispute highlights growing tension between brand-name pharma, telehealth platforms Novo Nordisk vowed to take legal action against Hims & Hers after the telehealth platform launched a cheaper, copycat version of the pharmaceutical giants Wegovy GLP-1 weight loss pill
niruri extract, called Uriston, for at least three months, while the rest served as controls
Therefore, in addition to GSSG accumulation, a decrease in Grx expression/activity may also lead to increased protein S -glutathionylation
Long-term use of Ipamorelin may support bone mineral density crucial for postmenopausal women and aging men
Medical billing and coding tasks are rather demanding, and it might make little economic or strategic sense for your practice to run these operations in-house
/assets/images/provider/photos/2798511.png)
